Sofia, Bulgaria, August 28, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 27, 2025 the Company sold 43 600 (forty-three thousand and six hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 108 248.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.

Sofia, Bulgaria, August 27, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 26, 2025 the Company sold 49 801 (forty-nine thousand eight hundred and one) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 123 510.05 on the Bulgarian Stock Exchange, the average price per share was BGN 2.48.

Sofia, Bulgaria, August 26, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 25, 2025 the Company sold 303 540 (three hundred three thousand five hundred and forty) treasury shares representing 0.06% of the share capital of the Company, at a total value of BGN 747 218.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, August 25, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 22, 2025 the Company sold 99 775 (ninety-nine thousand seven hundred and seventy-five) treasury shares representing 0.02% of the share capital of the Company, at a total value of BGN 244 852.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

Sofia, Bulgaria, August 22, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 21, 2025 the Company sold 17 126 (seventeen thousand one hundred and twenty-six) treasury shares representing 0.003% of the share capital of the Company, at a total value of BGN 41 961.96 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

Sofia, Bulgaria, August 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 20, 2025 the Company sold 68 049 (sixty-eight thousand and forty-nine) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 166 787.20 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.

София, Болгария, 20 августа 2025 г. – В соответствии с требованиями ст. 100т из ЗППЦБ, „Софарма“ АД (SFA: Болгарская фондовая биржа, SPH: Варшавская фондовая биржа) сообщает,

что во июля 2025 года Компания зафиксировала снижение продаж на 23% по сравнению с тем же месяцем прошлого года, в т.ч. 25% снижение продаж на внутреннем рынке и 22% снижение экспортных продаж.

За период с начала 2025 года в Компании зафиксировано рост продаж в размере 4%, в том числе 6% снижение продаж на внутреннем рынке и 12% рост экспортных продаж.

Sofia, Bulgaria, August 20, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 19, 2025 the Company sold 3 900 (three thousand nine hundred) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 9 603.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, August 19, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 18, 2025 the Company sold 1 100 (one thousand one hundred) treasury shares representing 0.0002% of the share capital of the Company, at a total value of BGN 2 707.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.

Sofia, Bulgaria, August 18, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 15, 2025 the Company sold 333 272 (three hundred thirty three thousand two hundred and seventy two) treasury shares representing 0.06% of the share capital of the Company, at a total value of BGN 803 834.80 on the Bulgarian Stock Exchange, the average price per share was BGN 2.41.